Basic Hematology Research
This multi-faceted hematology research program focuses on understanding basic cellular and molecular mechanisms that underlie the production and function of blood cells in health and disease. Major areas of interest include (1) basic mechanisms involved in regulating the production and terminal development of blood cells (hematopoiesis) and in regulating the expression of genes relevant to normal blood cell maturation and function, (2) regulatory molecules, cytokines, and hematopoietic growth factors that influence blood cell production from hematopoietic stem cells and progenitors, (3) blood cell membrane structure and function relevant to the maintenance of blood cell integrity, the tissue localization of hematopoietic progenitor cells, and the circulation and survival of mature blood cells, (4) acquired and congenital disorders of erythrocyte (red blood cell) production (erythropoiesis) and survival including anemias resulting from disturbances in the production or function of hemoglobin (e.g. thalassemias, sickle cell disease), (5) the molecular biology of heme and hemoglobin synthesis and turnover, (6) the metabolism, storage, and transport of iron and disorders resulting from disturbances in these processes, such as hemochromatosis and iron restricted anemias, (7) the metabolism, structure, and function of leukocytes (white blood cells) and myeloid progenitors, and (8) translational applications of new insights and knowledge gained from basic research in these areas towards the development of novel or improved approaches for the diagnosis, stratification, and treatment of hematologic diseases, with a particular emphasis on the development of disease biomarkers, gene targeted therapies, hematopoietic stem cell transplantation in heritable blood diseases, and the measurement and chelation of tissue iron in iron overload disorders.For more information, contact Dr. Daniel Wright, or Dr. Terry Rogers Bishop, Hematology Program Director.
Resources for Researchers
Clinical Research
Centers
Funding for Special Communities
NIDDK Staff
- Dr. Kristin Abraham, Cell Signaling and Diabetes Centers Program Director
- Dr. Guillermo Arreaza-Rubin, Director, Clinical Immunology, Type 1 Diabetes Program
- Dr. Terry Bishop, Hematology Research Programs Director
- Dr. Olivier Blondel, Director, Endocrine Systems Biology Program
- Dr. Arthur Castle, Director, Metabolomics and Informatics Programs
- Dr. Debuene Chang, Urology, Program Director Women's Urological Health
- Dr. Robert Karp, Director of the Genetics and Genomics Programs in Digestive Diseases and Nutrition
- Dr. Maren Laughlin, Senior Advisor for Integrative Metabolism
- Dr. Catherine McKeon, Senior Advisor for Genetic Research in Diabetes, Endocrinology and Metabolic Diseases
- Dr. Marva Moxey-Mims, Kidney Centers Program Director; Pediatric Nephrology Program Director; Applied Kidney SBIR Program Director
- Dr. Rebekah Rasooly, Deputy Director of the Division of Kidney, Urologic, and Hematologic Diseases
- Dr. Salvatore Sechi, Proteomic Program Director
- Dr. Jose Serrano, Director of the Liver and Biliary Program; Director of the Pancreas Program
- Dr. Daniel Wright, Hematology Research Programs Director
|
Funding Opportunities
Conferences
Related Study Sections
See Also
|
Page last updated: November 25, 2008